Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

86 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Possible association between non-invasive parameter of flow-mediated dilatation in brachial artery and whole coronary plaque vulnerability in patients with coronary artery disease.
Sawada T, Emoto T, Motoji Y, Hashimoto M, Kageyama H, Terashita D, Mizoguchi T, Mizuguchi T, Iwasaki M, Taira K, Okamoto H, Matsuo Y, Kim SK, Takarada A, Yokoyama M. Sawada T, et al. Among authors: terashita d. Int J Cardiol. 2013 Jul 1;166(3):613-20. doi: 10.1016/j.ijcard.2011.11.101. Epub 2011 Dec 14. Int J Cardiol. 2013. PMID: 22172589
Effect of 3-month repeated administration of miglitol on vascular endothelial function in patients with diabetes mellitus and coronary artery disease.
Emoto T, Sawada T, Hashimoto M, Kageyama H, Terashita D, Mizoguchi T, Mizuguchi T, Motodi Y, Iwasaki M, Taira K, Okamoto H, Matsuo Y, Kim SK, Takarada A, Yokoyama M. Emoto T, et al. Among authors: terashita d. Am J Cardiol. 2012 Jan 1;109(1):42-6. doi: 10.1016/j.amjcard.2011.08.005. Epub 2011 Sep 23. Am J Cardiol. 2012. PMID: 21944671
Comparisons of detailed arterial healing response at seven months following implantation of an everolimus- or sirolimus-eluting stent in patients with ST-segment elevation myocardial infarction.
Sawada T, Shinke T, Otake H, Mizoguchi T, Iwasaki M, Emoto T, Terashita D, Mizuguchi T, Okamoto H, Matsuo Y, Kim SK, Takarada A, Yokoyama M. Sawada T, et al. Among authors: terashita d. Int J Cardiol. 2013 Sep 30;168(2):960-6. doi: 10.1016/j.ijcard.2012.10.043. Epub 2012 Nov 17. Int J Cardiol. 2013. PMID: 23164597 Clinical Trial.
The apolipoprotein B/A1 ratio is associated with reactive oxygen metabolites and endothelial dysfunction in statin-treated patients with coronary artery disease.
Emoto T, Sawada T, Morimoto N, Tenjin T, Wakimoto T, Ikeda F, Sato C, Terashita D, Mizoguchi T, Mizuguchi T, Okamoto H, Matsuo Y, Kim SK, Takarada A, Yokoyama M. Emoto T, et al. Among authors: terashita d. J Atheroscler Thromb. 2013;20(7):623-9. doi: 10.5551/jat.16824. Epub 2013 May 10. J Atheroscler Thromb. 2013. PMID: 23665841 Free article.
Impact of cytochrome P450 2C19 loss-of-function polymorphism on intra-stent thrombi and lesion outcome after everolimus-eluting stent implantation compared to that after first-generation drug-eluting stent implantation.
Konishi A, Shinke T, Otake H, Nishio R, Sawada T, Takaya T, Nakagawa M, Osue T, Taniguchi Y, Iwasaki M, Kinutani H, Masaru K, Takahashi H, Terashita D, Shite J, Hirata K. Konishi A, et al. Among authors: terashita d. Int J Cardiol. 2015 Jan 20;179:476-83. doi: 10.1016/j.ijcard.2014.11.068. Epub 2014 Nov 6. Int J Cardiol. 2015. PMID: 25465810
Impact of CD14++CD16+ monocytes on plaque vulnerability in diabetic and non-diabetic patients with asymptomatic coronary artery disease: a cross-sectional study.
Yoshida N, Yamamoto H, Shinke T, Otake H, Kuroda M, Terashita D, Takahashi H, Sakaguchi K, Hirota Y, Emoto T, Amin HZ, Mizoguchi T, Hayashi T, Sasaki N, Yamashita T, Ogawa W, Hirata KI. Yoshida N, et al. Among authors: terashita d. Cardiovasc Diabetol. 2017 Aug 8;16(1):96. doi: 10.1186/s12933-017-0577-8. Cardiovasc Diabetol. 2017. PMID: 28789689 Free PMC article.
Impact of CD14++CD16+ monocytes on coronary plaque vulnerability assessed by optical coherence tomography in coronary artery disease patients.
Yamamoto H, Yoshida N, Shinke T, Otake H, Kuroda M, Sakaguchi K, Hirota Y, Toba T, Takahashi H, Terashita D, Uzu K, Tahara N, Shinkura Y, Kuroda K, Nagasawa Y, Nagano Y, Tsukiyama Y, Yanaka KI, Emoto T, Sasaki N, Yamashita T, Ogawa W, Hirata KI. Yamamoto H, et al. Among authors: terashita d. Atherosclerosis. 2018 Feb;269:245-251. doi: 10.1016/j.atherosclerosis.2018.01.010. Epub 2018 Jan 17. Atherosclerosis. 2018. PMID: 29407600
Effect of daily glucose fluctuation on coronary plaque vulnerability in patients pre-treated with lipid-lowering therapy: a prospective observational study.
Kuroda M, Shinke T, Sakaguchi K, Otake H, Takaya T, Hirota Y, Sugiyama D, Nakagawa M, Hariki H, Inoue T, Osue T, Taniguchi Y, Iwasaki M, Nishio R, Kinutani H, Konishi A, Hiranuma N, Takahashi H, Terashita D, Hirata KI. Kuroda M, et al. Among authors: terashita d. JACC Cardiovasc Interv. 2015 May;8(6):800-811. doi: 10.1016/j.jcin.2014.11.025. JACC Cardiovasc Interv. 2015. PMID: 25999102 Free article.
Morphological and pharmacological determinants of peri-procedural myocardial infarction following elective stent implantation: Optical coherence tomography sub-analysis of the PRASFIT-Elective study.
Uzu K, Shinke T, Otake H, Takaya T, Osue T, Iwasaki M, Kinutani H, Konishi A, Kuroda M, Takahashi H, Terashita D, Hirata KI, Saito S, Nakamura M, Shite J, Akasaka T. Uzu K, et al. Among authors: terashita d. J Cardiol. 2017 Dec;70(6):545-552. doi: 10.1016/j.jjcc.2017.05.002. Epub 2017 Jun 12. J Cardiol. 2017. PMID: 28619235 Free article. Clinical Trial.
86 results